These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2846934)

  • 1. Study on the receptor subtypes mediating the analgesic action of an enkephalin analog, Tyr-D-Met(O)-Gly-EtPhe-NHNHCOCH3.AcOH (EK-399).
    Doi T; Kuzuna S; Fujino M
    Jpn J Pharmacol; 1988 Aug; 47(4):409-15. PubMed ID: 2846934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the discriminative stimulus effect of an enkephalin analog, EK-399, in the rat].
    Nishida N; Yasuhara Y; Chiba S
    Nihon Yakurigaku Zasshi; 1991 Jun; 97(6):361-9. PubMed ID: 1651892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical dependence potential of an enkephalin analog, EK-399, in rats.
    Nishida N
    Jpn J Pharmacol; 1990 Aug; 53(4):443-50. PubMed ID: 2214369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance to delta- but not mu-opioid receptors in the spinal cord attenuates inhibition of the tail-flick response induced by beta-endorphin administered intracerebroventricularly in mice.
    Suh HH; Tseng LF
    Pharmacol Biochem Behav; 1990 Apr; 35(4):807-13. PubMed ID: 2161107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of enkephalin analogs, EK-209 and EK-399, in rats.
    Nishida N; Hasegawa Y; Chiba S; Wakimasu M; Fujino M
    Eur J Pharmacol; 1989 Dec; 174(1):71-6. PubMed ID: 2612579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous self-administration of an enkephalin analog, EK-399, by rats.
    Nishida N; Chiba S
    J Toxicol Sci; 1991 May; 16(2):75-86. PubMed ID: 1886174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between pharmacological and opiate receptor binding activities of tetrapeptide acylhydrazide analogs of enkephalin.
    Kawai K; Ishii H; Doi T; Tamura S; Shinagawa S; Fujino M
    Eur J Pharmacol; 1981 Jul; 72(4):297-304. PubMed ID: 6268417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
    Drower EJ; Stapelfeld A; Rafferty MF; de Costa BR; Rice KC; Hammond DL
    J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse.
    Vaught JL; Mathiasen JR; Raffa RB
    J Pharmacol Exp Ther; 1988 Apr; 245(1):13-6. PubMed ID: 2834533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
    Rady JJ; Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of naloxone with mu- and delta-opioid agonists on the respiration of rats.
    Pazos A; Flórez J
    Eur J Pharmacol; 1983 Feb; 87(2-3):309-14. PubMed ID: 6301857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid and substance P receptor adaptations in the rat spinal cord following sub-chronic intrathecal treatment with morphine and naloxone.
    Gouarderes C; Jhamandas K; Cridland R; Cros J; Quirion R; Zajac JM
    Neuroscience; 1993 Jun; 54(3):799-807. PubMed ID: 7687333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of opioid peptides on respiration and analgesia in rats.
    Flórez J; Pazos A
    Life Sci; 1982 Sep 20-27; 31(12-13):1275-7. PubMed ID: 6292613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential cross-tolerance between analgesia produced by alpha 2-adrenoceptor agonists and receptor subtype selective opioid treatments.
    Paul D; Tran JG
    Eur J Pharmacol; 1995 Jan; 272(1):111-4. PubMed ID: 7713142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of the affinity of naloxone at supraspinal and spinal opioid receptors in vivo: studies with receptor selective agonists.
    Heyman JS; Koslo RJ; Mosberg HI; Tallarida RJ; Porreca F
    Life Sci; 1986 Nov; 39(19):1795-803. PubMed ID: 3022095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reinforcing effects of the enkephalin analogs, EK-209 and EK-399, in rats.
    Nishida N; Hasegawa Y; Chiba S; Wakimasu M; Fujino M
    Eur J Pharmacol; 1989 Aug; 166(3):453-8. PubMed ID: 2806371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and beta-endorphin in mice.
    Suh HH; Tseng LF
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):67-71. PubMed ID: 1976234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [D-Pro10]-dynorphin(1-11) is a kappa-selective opioid analgesic in mice.
    Gairin JE; Gout R; Meunier JC; Cros J
    J Pharmacol Exp Ther; 1988 Jun; 245(3):995-1001. PubMed ID: 2898527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.